Transcription of Tethered Enzyme Technology (TET™) - CTL
{{id}} {{{paragraph}}}
Example: tourism industry
Tethered Enzyme Technology (TET™) - CTL
Phillip Owh | Tethered Enzyme Technology (TET ) Point-of-Care Testing for Brain Injuries Tethered Enzyme Technology (TET ) POINT-OF-CARE TESTING FOR BRAIN INJURIES Inventors: Alex Travis & Roy Cohen CTL Officer: Phillip Owh Phillip Owh | Tethered Enzyme Technology (TET ) Point-of-Care Testing for Brain Injuries Point-of-Care Testing (PoCT) The Problem Technology requirements: results & accuracy ( ) Market size: 2011: $ >> 2016: $ Time-critical pathologies: Brain Injuries/Stroke There is no available PoCT Technology ! Phillip Owh | Tethered Enzyme Technology (TET ) Point-of-Care Testing for Brain Injuries Stroke - 3rd leading cause of death in the US (>140,000/year). - #1 cause of serious, long-term disability. - 800,000 people/year (US), 15,000,000 worldwide. - 1 of 4 strokes occurs in people under the age of 65.
Phillip Owh | Tethered Enzyme Technology (TET™) – Point-of-Care Testing for Brain Injuries Stroke - 3 rd leading cause of death in the US ( >140,000/year ).
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: